Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction
- PMID: 2578296
- DOI: 10.1016/0304-4165(85)90256-9
Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction
Abstract
Kinetic characteristics of several heparin preparations and substitute heparins were determined to help understand the bases for activity differences. Several materials were highly active in factor Xa inhibition and the reaction rate at constant factor Xa concentration appeared to be predicted by the extent of intrinsic antithrombin III fluorescence change induced by the polysaccharide. Heparin fractions of different molecular weight and affinity for antithrombin III showed similar kinetic parameters in catalysis of the thrombin-antithrombin III reaction when these parameters were expressed on the basis of antithrombin III-binding heparin. The latter was determined by stoichiometric titration of the antithrombin III fluorescence change by the heparin preparation. However, the various heparin fractions showed very different specific activities per mg of total polysaccharide. This indicated that functional heparin molecules had similar kinetic properties regardless of size or antithrombin III-binding affinity and is possible because the Km for antithrombin III is determined by diffusion rather than by binding affinity. Substitute heparins and depolymerized heparin were poor catalysts for thrombin inhibition, due at least partially to their affinity for thrombin. This latter binary interaction inhibits thrombin reaction in the heparin-catalyzed reaction.
Similar articles
-
Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.Can J Biochem Cell Biol. 1984 Oct;62(10):975-83. doi: 10.1139/o84-125. Can J Biochem Cell Biol. 1984. PMID: 6509363
-
Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.Biochem J. 1984 Sep 15;222(3):571-8. doi: 10.1042/bj2220571. Biochem J. 1984. PMID: 6207810 Free PMC article.
-
Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.J Biol Chem. 1986 Nov 25;261(33):15467-73. J Biol Chem. 1986. PMID: 3782075
-
Molecular weight of heparin versus biologic activity. Some additional considerations.Semin Thromb Hemost. 1985 Jan;11(1):29-33. doi: 10.1055/s-2007-1004355. Semin Thromb Hemost. 1985. PMID: 2579437 Review. No abstract available.
-
Rationale behind the development of low molecular weight heparin derivatives.Semin Thromb Hemost. 1985 Jan;11(1):13-6. doi: 10.1055/s-2007-1004352. Semin Thromb Hemost. 1985. PMID: 2579436 Review.
Cited by
-
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.Drugs. 1990 Oct;40(4):498-530. doi: 10.2165/00003495-199040040-00003. Drugs. 1990. PMID: 1964634 Review.
-
Antithrombotic effect of ligustrazine hydrochloride injection on the model of induced arteriovenous shunt thrombosis.J Res Med Sci. 2013 Aug;18(8):704-6. J Res Med Sci. 2013. PMID: 24379848 Free PMC article.
-
Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.Biochem J. 1989 Sep 1;262(2):651-8. doi: 10.1042/bj2620651. Biochem J. 1989. PMID: 2529852 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical